Overview

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

Status:
Completed

Trial end date:
2000-10-01

Target enrollment:
0

Participant gender:
All

Summary

The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Pancreatin
Pancrelipase

Criteria

Inclusion Criteria:

- Subjects will have either bothersome upper abdominal discomfort, bloating (feeling of
abdominal distention) or belching following meals for at least 12 month's duration.
Subjects must have had a normal upper gastrointestinal endoscopy and/or upper GI
series during the preceding three years.

Exclusion Criteria:

- Individuals with a history suggestive of organic disease such as recent weight loss,
nausea, vomiting, GERD, recent changes in bowel habits will be excluded from the
study.